For the 8th year in succession, EAPM will be present at the prestigious ESMO Congress and will, for the fifth time, be hosting a satellite meeting as part of the events. In the same way as our own recent events, the focus will be on bringing innovation into healthcare systems, but with very specific items on the Alliance agenda, which will be on the issue of biomarkers and molecular diagnostics.

EAPM’s roundtable is currently scheduled to take place on 18 September. 

The situation caused by the novel coronavirus, it’s effect on EU healthcare systems, and the fall-out going forward, will be among the hottest topics.

The roundtables will commence at 08.00 and finish at 16.00, and will feature three two-hour sessions. These are currently scheduled as follows:

08.00 - 10.00 - Session 1: Tumor Agnostic

10.30 - 12.30 - Session 2:  Biomarkers and Molecular Diagnostics

13.30 - 15.30 - Session 3: Utilising Real-World Evidence in a healthcare setting

15.30 - 16.00 - Closing Session

Please find here the agenda.

Please find here the agenda for the ESMO Lung Cancer Roundtable.

Please Register here to attend the roundtable.